Background: Triclosan-coated sutures (TCS) were developed to reduce the risk of surgical-site infection (SSI). Level 1A evidence of effectiveness has been presented in various recent meta-analyses, yet well designed RCTs have not been able to reproduce these favourable results. The aim of this study was to evaluate all available evidence critically with comprehensive analysis to seek a more reliable answer regarding the effectiveness of TCS in the prevention of SSI.
Introduction
Surgical-site infection (SSI) is one of the most common healthcare-associated infections, and causes increased morbidity, mortality and prolonged hospital stay 1 -3 . Moreover SSI increases healthcare costs in the USA by up to $1⋅6 billion per year 2 . SSIs are multifactorial, with risks associated with both the patient and the surgical procedure. One of these procedural factors is the suture used, which has been shown to be a potential nidus for infection 4, 5 . Triclosan is a bactericide that has been in common use for over 30 years 6 ; in an effort to reduce SSI, sutures coated with triclosan have been developed.
In vitro and in vivo studies have shown that triclosan coating kills a range of bacteria associated with SSI 7 , and inhibits colonization of those bacteria on the suture surface 8 -11 . Triclosan was introduced to the medical market in the 1970s, and as a suture coating in 2002. RCTs have been conducted to investigate its effect on SSI in various surgical procedures and with different types of suture. Several meta-analyses have been published showing different results, but also a wide variety in study and data selection ( Table 1) 12 -42 . None of these previously published meta-analyses used meta-regression to substantiate subgroup effects and assess generalizability of the overall effect across subgroups. Nor did they employ trial sequential analysis (TSA) to assess the risk of random error, or Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to assess the quality of the evidence. Consequently, critical questions on the interpretation of the data are left unanswered. Translation of these results to clinical practice remains problematic.
Moreover, two recent and well designed RCTs 17, 30 were not able to reproduce the positive results from previous meta-analyses, raising questions regarding the correctness of these results 13 -18,30 . Thorough analysis of the evidence, taking into account clinically and methodologically relevant subgroup differences, the risk of random error and the quality of evidence, is needed.
The aim of this study was to find a more definitive answer to the question of efficacy of triclosan-coated sutures (TCS) in the prevention of SSI by critical evaluation of all available evidence with the use of metaregression, TSA and GRADE methodology.
Methods
This systematic review is reported according to the validated methods of the PRISMA statement 43 .
Study identification
A systematic literature search was carried out using PubMed, MEDLINE, Embase and Cochrane Library databases (January 1990 to November 2015) 43 . The search terms used were: triclosan, antimicrobial, antiseptic, antibiotic, antibacterial, biocide, suture, polyglactin 910, polydioxanone, glycolide E-caprolactone co-polymer, Vicryl, PDS, poliglecaprone 25, plus, surgical wound infection, surgical site infection, SSI, surgical infection, postoperative wound infection. These search terms were combined with the highly sensitive search strategy of Cochrane to identify all RCTs 44 . No language restriction was applied. The full search strategy is available in Table S1 (supporting information). No prewritten protocol was published for this review.
Study selection
Two authors independently considered the studies retrieved from the search for potential eligibility by screening titles and abstracts. All RCTs comparing the effect of TCS on the incidence of SSI with that of exactly the same, but uncoated, sutures were included. Exclusion criteria were in vitro studies, animal studies, non-randomized studies and studies with incomparable suture types in the control group. When title and abstract indicated potential eligibility based on these criteria, or insufficient information was supplied for assessment, the full-text article was obtained and assessed by both authors independently for final inclusion. Any disagreements were resolved through discussion or, when necessary, after consultation with the senior authors. Among the retrieved studies, previously conducted meta-analyses adhering to the same criteria were identified for evaluation of the existing evidence.
Risk of bias
Two authors appraised each study critically using the Cochrane Collaboration's tool for assessing risk of bias 45 and displayed summary figures generated by Review Manager version 5.3 (The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark; 2008). Publication bias was assessed using a funnel plot 46 . Funding and other potential conflicts of interest were addressed separately and distinguished in the funnel plot. Studies were defined as having a potential conflict of interest when funding from, or services for, industry were described, as unclear when conflict of interest was not described or the funding source was not reported, and as having no potential conflict of interest when the authors explicitly stated there was none.
Data abstraction
Two authors reviewed each eligible paper independently. Data abstraction was done using a predefined evidence table, and data were then compared. The outcome of interest was SSI. Data collection for each paper included year and type of publication, country, design, a priori sample size calculation, participants, type of surgery, suture under investigation, Centers for Disease Control and Prevention (CDC) wound classification 47 , SSI definition used, duration of follow-up, use of preoperative antibiotic prophylaxis, possible conflicts of interest as declared by the authors, and adverse events.
Statistical analysis
The endpoint of interest, SSI, was expressed using pooled relative risk (RR) with the corresponding 95 per cent confidence interval. A random-effects model (Mantel-Haenszel method) was used to account for potential clinical heterogeneity 48 . Forest plots were constructed, and P < 0⋅050 was considered to be statistically significant. Heterogeneity was assessed using the I 2 statistic, and the χ 2 test for heterogeneity was performed, with P < 0⋅100 considered as statistically significant heterogeneity. Subgroup analyses were planned a priori for CDC wound classification and suture type. Suture type was assessed in a two-category subgroup analysis as the largest trial, showing contradictory results with the most recent systematic review, used triclosan-coated polydioxanone sutures whereas most trials in the systematic review used triclosan-coated polyglactin 910 sutures. There is a e120 S. W. de Jonge, J. J. Atema, J. S. Solomkin and M. A. Boermeester Table 1 Previous systematic reviews on the effect of triclosan-coated sutures Chang et al. 12 (n = 836) Wang et al. 13 (n = 3720)
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substantial body of evidence 49 -51 that bacterial adherence to a monofilament suture, such as polydioxanone, differs from that of a braided suture such as polyglactin 910. Moreover, different suture types may be used in different circumstances. CDC wound classification was assessed rather than specific procedure type, as contamination is a classical risk factor for SSI and procedure types may have the same SSI risk 47,52 -54 . Subgroups were constructed for exclusively clean procedures (CDC wound class I) and non-clean procedures (CDC wound classes II-IV).
All analyses were tested for sensitivity to study quality. Studies with poor methodological design have a tendency to overestimate treatment effect 55 -57 . High study quality should produce reproducible results with high external validity. Three quality categories were assessed: all publications, including congress abstracts of which quality is uncertain owing to limited description of methodology; peer-reviewed full-text publications; and strictly selected high-quality studies. High-quality studies adhered to the methodological principles to minimize errors in surgical trials, as described by Farrokhyar and colleagues 58 : adequate randomization, concealment of allocation, blinding, intention-to-treat analysis, complete follow-up, reliable accurate outcome measure, and an a priori sample size calculation. The CDC criteria for SSI are a reliable accurate outcome measure for SSI 59 . Post hoc subgroup analyses were conducted to explore the effect of possible conflicts of interest and the effect of adequate use of antibiotic prophylaxis on the overall analysis.
Metaregression was undertaken to investigate the association of subgroup characteristics with the intervention effect, and to assess generalizability of the outcome across subgroups 60 . Cumulative meta-analyses are in danger of producing type I errors owing to an increased risk Triclosan-coated sutures for prevention of surgical-site infection e121 of random error when sparse data are analysed, and to repeated significance testing when meta-analyses are updated with new trials 61 -63 . To assess the openness of the effect size of the present meta-analysis to change according to potential future data and thereby the risk of type I error and the need for future data, a post hoc TSA was done. TSA combines an estimation of required information size (combined sample size of the included trials) with an adjusted threshold for statistical significance in the cumulative meta-analyses 62, 64, 65 . A model variance-based diversity-adjusted information size was used for the TSA based on α = 0⋅05, β = 0⋅20 (power of 80 per cent) and a clinically relative risk reduction (RRR) of 15 per cent. The conservative trial sequential monitoring boundaries were set by O'Brien-Fleming as the α spending function. The cumulative Z-curve of each cumulative meta-analysis was calculated and plotted against the above monitoring boundaries. The crossing of the cumulative Z-curve into the trial sequential monitoring boundary for benefit indicates that a sufficient level of evidence has been reached, and no further trials may be needed to demonstrate the superiority of the intervention. If the cumulative Z-curve does not cross any of the trial sequential monitoring boundaries, there is probably insufficient evidence to reach a conclusion, and additional trials may be required. If the cumulative Z-score curve crosses into the futility area boundary, future trials are unlikely to alter the trend of evidence.
Statistical analyses were conducted using Review Manager version 5. 
Grading the evidence
All data from the eligible trials were analysed using the GRADE system with the GRADEpro guideline development tool (http://gdt.guidelinedevelopment.org/), to define the quality of the evidence 66 .
Results

Existing meta-analyses
Several meta-analyses have been conducted with varying included studies ( Table 1) 12 -42 . These differences cannot be explained by publication date only. Some authors 14, 16 selected studies based on the type of publication, leading to publication bias 44 . Others 12 -16,18 included studies with a Records identified through database searching n = 708
Additional records identified through other sources n = 2
Records excluded n = 357
Full-text articles excluded n = 19*
Full-text articles assessed for eligibility n = 40
Records screened after duplicates removed n = 397
Studies included in qualitative synthesis n = 21
Studies included in quantitative synthesis
(meta-analysis) n = 21 Table S2 (supporting information) non-comparable suture type in the control group, inappropriate for the assessment of the intervention effect. Other differences in study selection, unexplained by publication date, can be explained only by differences in search efficacy.
Present systematic review
The search retrieved 708 records of possible relevance. Two additional records were identified through other sources. After removal of duplicates, 397 records were screened and 357 were excluded based on title and abstract. Forty full-text publications were retrieved and assessed for eligibility; 21 trials were included in the final analysis ( Fig. 1 ; Table S2 , supporting information).
Study characteristics
Study characteristics are listed in patients undergoing vascular surgery or vein harvesting, one 21 included patients undergoing CSF shunt implantation and two studies 27, 33 included patients undergoing cardiac surgery. Nine studies included non-clean (CDC wound class II-IV) surgery. Of these, one study 42 included patients undergoing head and neck surgery, one 41 included pilonidal cyst surgery and seven studies 19, 22, 28, 30, 31, 38, 40 included patients undergoing an abdominal operation. Five studies included both clean and non-clean procedures, of which two 24, 26 included a variety of procedures, two 17, 37 included abdominal procedures and one 20 umbilical trocar incisions after laparoscopy. Of these, three 17, 26, 37 reported SSI for clean and non-clean procedures separately; the other two 20, 24 were classified as non-clean. Twelve studies 17, 19, 22, 26, 27, 30, 34, 35, 37 -40 used the CDC criteria for SSI, two 21, 32 defined SSI on the basis of a positive wound culture, three 20, 24, 33 on the basis of clinical signs of infection, one 42 on clinical signs of infection or neck skin necrosis, and in three studies 28 
Risk of bias
Critical appraisal of the 21 studies showed differences in methodological quality. All studies were assessed using the Cochrane collaboration risk-of-bias tool (Fig. 2) . Thirteen studies 17 17 Thimour-Bergström et al. 39 Turtiainen et al. 34 Baracs et al. 19 Chen et al. 42 Ford et al. 24 Galal and El-Hindawy 26 Isik et al. 27 Justinger et al. 37 Arslan et al. 41 Defazio et al. 20 Khachatryan et al. 28 Singh et al. 33 Yam and Orlina 40 Mattavelli et al. 30 Mingmalairak et al. 22 Nakamura et al. 38 Rasic et al. 31 Rozzelle et al. 21 Seim et al. 32 Williams et al. 35 Subtotal Subtotal Subtotal Total Heterogeneity: τ 2 = 0·01; χ 2 = 2·52, 2 d.f., P = 0·28; I 2 = 21% Test for overall effect: Z = 1·14, P = 0·25 Heterogeneity: τ 2 = 0·05; χ 2 = 16·76, 12 d.f., P = 0·16; I 2 = 28% Test for overall effect: Z = 2·58, P = 0·010 Heterogeneity: τ 2 = 0·00; χ 2 = 2·55, 4 d.f., P = 0·64; I 2 = 0% Test for overall effect: Z = 3·36, P < 0·001 Heterogeneity: τ 2 = 0·04; χ 2 = 28·53, 20 d.f., P = 0·10; I 2 = 30% Test for overall effect: Z = 3·60, P < 0·001 Test for subgroup differences: χ 2 = 5·81, 2 d.f., P = 0·05; I 2 = 65·6% Fig. 2 Forest plot of meta-analysis and risk-of-bias table, comparing the effect of triclosan-coated sutures (TCS) with the same non-coated sutures (NCS) on the risk of surgical-site infection (SSI), stratified for study quality. A Mantel-Haenszel random-effects model was used. Relative risk is shown with 95 per cent confidence intervals. A, random sequence generation (selection bias); B, allocation concealment (selection bias); C, blinding of participants and personnel (performance bias); D, blinding of outcome assessment (detection bias); E, incomplete outcome data (attrition bias); F, selective reporting (reporting bias); G, other bias and four studies 20 Six studies had a high risk of attrition bias owing to incomplete outcome data reporting. In one study 19 , 17 per cent of eligible patients were not included in the final analysis for various reasons, with 25 per cent more missing data in the intervention group. Another study 24 had nearly 15 per cent loss to follow-up, with over 50 per cent more in the intervention group. In a multicentre trial conducted in Egypt 26 , the results from only one hospital were reported. A single-centre Triclosan-coated sutures for prevention of surgical-site infection e125 study from Germany 37 reported a per-protocol analysis leaving out more than 10 per cent of the initially eligible patients, of which over 40 per cent more missing data belonged to the intervention group; there was no information on the distribution of the different reasons for exclusions over the two groups. A single-centre study conducted in the UK 35 had 15 per cent loss to follow-up, with 58 per cent more missing data in the control group. Finally there was a preliminary report 22 from 2009 from one study of which the final results had still not been published in 2015. All other studies 17,20,21,27,28,30 -34,38-42 had no missing data. Four studies had a high risk of reporting bias due to selective reporting. In three of these studies 28, 31, 41 , there was no definition of the primary endpoint. The other study 26 was assessed as at high risk of reporting bias because the total intervention and control group sizes differed between different categorical representations of the data in the report. Nine studies 20, 21, 24, 32, 33, 35, 39, 40, 42 used definitions or follow-up duration deviating from the broadly accepted CDC standard, with no published protocol available. These studies were assessed as having an unclear risk of reporting bias. The other eight studies 17, 19, 22, 27, 30, 34, 37, 38 had a low risk of reporting bias.
In three studies 21, 30, 32 there was a high risk of other bias. Of these, one study 21 continued accrual after indifferent interim analyses and stopped when a significant difference in favour of the intervention was obtained. This same study 21 reported an infection risk in the control group twice as high as that expected based on the literature. The two other studies 30, 32 assessed as having a high risk of bias had baseline differences with a likely effect on the primary endpoint. Five studies were assessed as having an unclear risk of other bias, as only the abstracts had been published. The overall risk of bias was assessed as serious (Fig. 2) .
Potential conflicts of interest and funding
Six studies reported a potential conflict of interest 17, 21, 24, 35, 37, 39 ; of these, three 17, 21, 35 reported conflicts of interest related to services for the developer of the product under investigation and five 17, 24, 35, 37, 39 declared funding by the product developer. Seven studies 19, 22, 27, 30, 32, 39, 42 stated that there were no potential conflicts of interest. However, one 39 was funded by the developer of the product under investigation and two 19, 32 did not report their source of funding. Eleven studies 20, 24, 26, 28, 31, 33, 34, 37, 38, 40, 41 made no statement on potential conflict of interest. Of these, two studies 24, 37 were funded by the product developer and eight 26, 28, 31, 33, 34, 38, 40, 41 did not report the source of funding.
Overall, only six studies 20 -22,27,30,42 reported independent sources of funding. In summary, six studies 17, 21, 24, 35, 37, 39 had a potential conflict of interest, four 22, 27, 30, 42 had no potential conflict of interest and 11 19,20,26,28,31 -34,38,40,41 had an unclear potential conflict of interest. In the funnel plot for publication bias, potential conflicts of interest are distinguished (Fig. S1, supporting information) .
Publication bias
The distribution of studies in the funnel plot was symmetrical. No evidence was found for publication bias in this analysis (Fig. S1, supporting information) . Distinction of potential conflicts of interest and study quality in the funnel plot showed a tendency towards no effect for independent high-quality studies, but no assumption can be made based on these findings.
Meta-analysis
In a meta-analysis of all the 21 trials yielded by the search, SSIs were reduced significantly by the use of TCS compared with a comparable uncoated variant (RR 0⋅72, 95 per cent c.i. 0⋅60 to 0⋅86; P < 0⋅001). Heterogeneity was low to moderate (χ 2 = 28⋅53, P = 0⋅10, I 2 = 30 per cent). At a risk of 138 SSIs per 1000 procedures, the use of TCS had 39 (95 per cent c.i. 19, 55) fewer SSIs per 1000 procedures and a number needed to treat of 25. The effect was robust to sensitivity analysis for peer-reviewed full-text publications (RR 0⋅77, 0⋅64 to 0⋅93; P = 0⋅006), but could not be substantiated in a strict selection of high-quality studies (RR 0⋅87, 0⋅68 to 1⋅11; P = 0⋅25) ( Fig. 2 and Table 3 ).
Subgroup analysis
The results of the subgroup analyses are presented in Table 3 and Figs S2-S15 (supporting information ) . In subgroup analysis for suture type, the effect could be substantiated for only polyglactin 910. This was robust in all publications (RR 0⋅69, 95 per cent c.i. 0⋅55 to 0⋅85; P < 0⋅001) and in peer-reviewed full-text publications (RR 0⋅75, 0⋅59 to 0⋅95; P = 0⋅02). In a strict selection of high-quality studies, the effect could not be substantiated. For polydioxanone there was no significant effect of TCS in the prevention of SSI. In subgroup analysis for CDC wound classification, the effect was substantiated for clean (RR 0⋅71, 0⋅57 to 0⋅89; P = 0⋅003) and non-clean (RR 0⋅74, 0⋅58 to 0⋅93; P = 0⋅01) wounds in all publications. In a sensitivity analysis for study quality, only the effect in clean surgical procedures was robust to selection of peer-reviewed full-text publications (RR 0⋅75, 0⋅60 to 0⋅93; P = 0⋅009); in Values in parentheses are 95 per cent confidence intervals. *Includes studies with exclusively clean or contaminated surgery and studies with both types of surgery; †studies included exclusively clean surgery; ‡studies included exclusively non-clean surgery; §number of studies does not add up to the total of 21 as three studies are divided over two subgroups; ¶total number of patients differs from the original unstratified total because one study reported different numbers in the stratification for contamination. TCS, triclosan-coated sutures; NCS, non-coated sutures; n.a., not available; CDC, Centers for Disease Control and Prevention; AP, antibiotic prophylaxis.
non-clean wounds it was not. In a selection of high-quality studies, the effect in both clean and non-clean procedures could not be substantiated. When suture type and CDC wound classification were combined, the effect of triclosan-coated polyglactin 910 was substantiated in all publications for clean and non-clean procedures (clean: RR 0⋅70, 0⋅53 to 0⋅93, P = 0⋅01; non-clean: RR 0⋅67, 0⋅49 to 0⋅93, P = 0⋅02). However, only the effect in clean procedures could be substantiated in peer-reviewed full-text publications (RR 0⋅76, 0⋅59 to 0⋅99; P = 0⋅04); in a selection of high-quality studies, neither could be substantiated. In subgroup analysis of polydioxanone and CDC wound classification there was no significant effect on the prevention of SSI. However, meta-regression showed no significant association between effect size and suture type (P = 0⋅41) or contamination (P = 0⋅71) ( Table 3) , and thus justified generalization of the overall effect across subgroups. Similar results were yielded in peer-reviewed full-text publications.
The high-quality study selection comprised too few data for meta-regression.
In a post hoc subgroup analysis based on description of preoperative antibiotic prophylaxis, the effect could be substantiated in both the subgroup that did (RR 0⋅75, 0⋅61 to 0⋅92) and did not (RR 0⋅66, 0⋅46 to 0⋅93) describe preoperative antibiotic prophylaxis (Fig. S16, supporting  information) . Post hoc subgroup analysis based on potential conflicts of interest did show subgroup differences: the effect was substantiated in studies with potential conflicts of interest (RR 0⋅69, 0⋅50 to 0⋅94) and unclear potential conflicts of interests (RR 0⋅64, 0⋅48 to 0⋅85), but not in studies with no potential conflicts of interest (RR 1⋅04, 0⋅73 to 1⋅50) (Fig. S17, supporting information) . However, meta-regression analysis showed no significant association between effect size and potential (P = 0⋅102) or unclear (P = 0⋅053) conflict of interest when no potential conflict of interest was used as a reference ( Table 3) .
Trial sequential analysis
For TSA of all 21 trials included in the meta-analysis, the adjusted optimal information size, based on a RRR (Fig. 3) . The effect was substantiated for peer-reviewed full-text publications, but not in a strict selection of high-quality studies (Figs S18 and S19, supporting information).
Grading the evidence
As all included studies were RCTs, the starting quality of the evidence was high. There was substantial risk of bias in some studies. Overall, the risk of bias was assessed as serious. There was no serious inconsistency of results. Heterogeneity was low, all confidence intervals overlapped and the I 2 value was low to moderate. There was no indirectness. Imprecision was assessed as not serious, as the trial sequential monitoring boundary for benefit was crossed and the overall 95 per cent confidence interval did not cross the treatment effect. Overall, the quality of evidence was moderate.
Adverse events
None of the identified studies described adverse events attributable to the intervention.
Discussion
GRADE assessment shows moderate quality of evidence in 21 trials including 6462 patients that TCS are effective in reducing SSI. In subgroup analysis for CDC wound classification and suture type, the effect seemed to be attributable to studies including polyglactin 910-coated sutures and clean procedures. However, meta-regression showed no significant association between either suture type or CDC classification and effect size, thus justifying generalization of the overall effect across subgroups. As a result of the bias effect, it is likely that the estimated effect of RRR of 25⋅6 per cent and number needed to treat of 28 is an overestimation. In TSA a clinically relevant RRR of 15 per cent was confirmed in two of the three sensitivity analyses, resulting in an absolute risk reduction of approximately 2 per cent and number needed to treat of 50.
In July 2014, the largest conducted trial on this topic was published 17 . With a sample size of 1185 patients and state-of-the-art methodology, a multicentre RCT such as this should approach, if not show, the truth. In contrast to the previous meta-analysis, no significant effect of TCS was found. Another study, published early 2015 by Mattavelli and colleagues 30 , was also unable to reproduce the optimistic results of previous meta-analyses. However, these authors, despite good randomization methods, were unable to exclude baseline imbalances that could have interfered with the primary outcome. In particular, the findings by Diener and co-workers 17 challenge the credibility of the previous meta-analyses. The present analysis gives a transparent overview of all published evidence, and rigorous analysis of its quality and robustness. On the whole, triclosan coating is effective, but effect size differs substantially among subgroups. It has proved to be effective in studies using polyglactin 910 sutures, but not in those employing polydioxanone. In addition, the effect appears to be more robust in clean procedures. These findings put the results of Diener et al. 17 in perspective, as these authors investigated polydioxanone in a population with mostly non-clean procedures.
The effect size varied among the different subgroup and sensitivity analyses. A possible explanation for the difference in effect size between suture types might be found in bacterial adherence to different sutures. Bacterial adherence to monofilament sutures such as polydioxanone is lower than that to braided sutures such as polyglactin 910 49 -51 . Masini and colleagues 67 showed that the addition of triclosan coating reduced the bacterial adherence of polyglactin 910 to the level of that in uncoated monofilament sutures. This indicated that a polyglactin 910 suture might have more potential to become a nidus of infection than a monofilament suture, and thereby benefit more from an active antibacterial coating. Moreover, polydioxanone is used mostly to close the fascia, whereas polyglactin 910 is used to close subcutaneous tissue and skin. The majority of SSIs are superficial 68 -70 . In studies investigating the effect of triclosan-coated polydioxanone, up to 90 per cent of detected SSIs were superficial 17, 19 . This indicates that the majority of wound infections described in these studies occurred in a different anatomical layer from that for which the intervention was used.
The fact that the effect of triclosan coating was more robust in studies investigating clean procedures is puzzling. However, in the meta-analysis, the control group event rate did not differ much between clean procedures and non-clean procedures (13⋅0 versus 14⋅4 per cent respectively). A possible explanation could be a difference in causative micro-organisms between clean and non-clean surgery, but the broad effectiveness of triclosan to pathogens associated with SSI makes this less likely. Despite the effect size differences, meta-regression showed no significant association with either suture type or CDC wound classification and effect size, justifying generalization of the overall effect across subgroups. There was a negative correlation between study quality and effect size, which indicates a substantial bias effect among the published trials and an overestimation of the true effect 55 -57 . An important finding is that researchers in this field have failed systematically to eliminate concerns of bias. Methodological challenges in surgical trials have been described extensively, and should be overcome with careful design 58, 71 . Poor reporting was addressed by Balasubramanian and colleagues in 2006 72 . In 2008, Knobloch et al. 73 reported that only 16 per cent of all RCTs referenced the CONSORT statement, and poor reporting of surgical trials remains a concern 74 . One limitation here is that no prewritten protocol was published for this review. In addition, being a meta-analysis the data are not based on original observations but on previous reports of observations, thereby limiting the possibilities of individual patient data analysis and incorporating heterogeneity and the risk of building evidence on previous errors. The available evidence and included studies have substantial methodological flaws. More than 60 per cent of the included studies used outcome definitions other than, or not exactly matching, the widely accepted CDC criteria 47 . An important part of the aim of the present study was to take into account all available evidence, so it was decided to define SSI by investigators' discretion. This limitation is taken into account in the risk-of-bias assessment, which is part of the GRADE assessment. When a strict selection was made using predefined criteria of high quality, only three studies met the criteria for analysis and no significant effect was seen. Under those conditions, TSA showed that a further 4787 patients would need to be randomized in order to establish evidence for a possible effect of TCS in trials of high-quality standard. However, study quality is addressed in GRADE assessment by downgrading the quality of evidence for risk of bias. With the presented moderate quality of evidence based on a large number of trials, it is not thought justified to expose thousands of patients to randomization of an intervention that has been tested so rigorously.
GRADE assessment shows moderate quality of evidence that TCS are effective in reducing SSI. TSA shows that the effect was robust, and additional data are not likely to alter the summary effect, although the true effect may be somewhat smaller than the estimated effect.
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